Fourth Dimension Wealth’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$85.2K Buy
3,540
+174
+5% +$4.55K 0.03% 209
2026
Q1
$94.5K Sell
3,366
-169
-5% -$4.5K 0.04% 178
2025
Q4
$88K Buy
3,535
+593
+20% +$15K 0.03% 186
2025
Q3
$75K Sell
2,942
-98
-3% -$2.42K 0.03% 193
2025
Q2
$73.7K Buy
3,040
+502
+20% +$11.7K 0.03% 192
2025
Q1
$64.3K Sell
2,538
-90
-3% -$2.35K 0.03% 199
2024
Q4
$74.5K Buy
+2,628
New +$71.3K 0.04% 181

Other funds holding PFE

Fourth Dimension Wealth's PFE Position: Q2 2026 in Review

Fourth Dimension Wealth increased its Pfizer (PFE) stake by 5.2% in Q2 2026, buying an estimated $4.55K and bringing the position to 3,540 shares worth $85.2K. The position accounts for 0.03% of the portfolio, ranked #209.

Fourth Dimension Wealth first reported a position in PFE in Q4 2024 and has held it in 7 quarters since. The position peaked at $94.5K in Q1 2026. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Fourth Dimension Wealth held 3,540 shares of Pfizer worth $85.2K as of Q2 2026.
  • Fourth Dimension Wealth bought 174 Pfizer shares in Q2 2026, an estimated $4.55K.
  • Pfizer made up 0.03% of Fourth Dimension Wealth's portfolio in Q2 2026, its #209 holding.
  • Fourth Dimension Wealth first reported a position in Pfizer in Q4 2024 and has held it in 7 quarters since.
  • Fourth Dimension Wealth's Pfizer position peaked at $94.5K in Q1 2026.
  • 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Fourth Dimension Wealth's 13F filing for Q2 2026, filed 31 Jul 2026.